Related Experiment Video
Updated: May 17, 2026
09:36
Safety Precautions and Operating Procedures in an (A)BSL-4 Laboratory: 4. Medical Imaging Procedures
Published on: October 3, 2016
BMP-2: biological challenges to its clinical use.
1Department of Periodontology and Implant Dentistry, New York University College of Dentistry, New York, NY, USA. razzos01@nyu.edu
The New York State Dental Journal
|October 23, 2012
Summary
Protein therapy using bone morphogenetic proteins (BMPs) shows short-term bone growth but faces long-term challenges. Biological obstacles compromise bone maintenance, questioning the sustained efficacy of BMP-2 for bone regeneration.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Oral and Maxillofacial Surgery
Background:
- Protein therapy with osteogenic factors, particularly bone morphogenetic proteins (BMPs), is explored for bone regeneration.
- BMP-2, delivered via absorbable collagen sponge (ACS), received FDA approval in 2007 for craniofacial applications.
- While short-term bone augmentation is documented, long-term clinical outcomes and reproducibility of BMP-2 remain unproven.
Purpose of the Study:
- To review biological obstacles affecting long-term bone maintenance after BMP-2 application.
- To highlight the significance of these obstacles within the oral environment.
- To discuss the emerging ambiguities regarding the clinical safety of BMP-2.
Main Methods:
- Literature review of studies on BMP-2 efficacy and long-term outcomes.
- Analysis of biological factors impacting bone volume maintenance.
- Discussion of clinical safety and efficacy concerns in the oral environment.
Main Results:
- Short-term bone augmentation with BMP-2 is frequently reported (up to 16 weeks).
- Significant biological obstacles hinder the maintenance of initially formed bone volume.
- Long-term clinical data on BMP-2 efficacy and safety are insufficient and raise concerns.
Conclusions:
- Biological factors are critical for successful long-term bone regeneration.
- Current protein therapies, including BMP-2, may be ineffective for prolonged bone maintenance.
- Further research is needed to address biological obstacles and ensure the long-term success of bone regenerative therapies.
Related Concept Videos
01:28Drug Products: Biologics, Biosimilars and Interchangeables
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:20Measurement of Bioavailability: Pharmacodynamic Methods
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).